GERD/Acid Reflux
News Category

American Heart Association Recognizes Outpatient Care Organizations in All 50 States for Cardiovascular Risk Factor Management
The American Heart Association awards more than 2,700 outpatient care organizations across all 50 states for improving management of high blood pressu...

Simple Waist-to-Height Ratio Emerges as Global Screening Tool for Pediatric Fatty Liver Disease
A new international study finds that waist-to-height ratio is a reliable, low-cost screening tool for pediatric MASLD across diverse ethnic and geneti...

New Bilingual Telehealth Clinic Launches to Address GLP-1 Access Gap for Latino Patients
Sol y Vida Clinic, a bilingual telehealth platform, launched nationwide to tackle the stark disparity in GLP-1 medication access for Hispanic patients...

Companies Rethink GLP-1 Drug Coverage as Costs and Questions Mount
As GLP-1 drug use surges, many U.S. companies are discontinuing coverage in employee health plans, prompting a deeper look into the reasons and implic...

Lakewood-Amedex Biotherapeutics Joins B2i Digital as Featured Company Ahead of Phase 2a Trial for Nu-3 in Infected Diabetic Foot Ulcers
Lakewood-Amedex Biotherapeutics, a clinical-stage biotech developing the novel Bisphosphocin class of antimicrobials, becomes a B2i Digital Featured C...

HCN Global and Society for Health Communication Launch New Webinar Series to Tackle Structural Barriers in Preventive Care and Maternal Health
HCN Global expands its Leadership for a Culture of Health series with a new partnership to address systemic barriers in preventive care and maternal h...

Study Finds Early Artery Damage in Young Adults, Urging Earlier Heart Health Prevention
A new study reveals that nearly 80% of young adults have early signs of cardiovascular-kidney-metabolic syndrome, linking advanced stages to arterial ...

Nearly 23 Million U.S. Adults May Be Newly Eligible for Blood Pressure Medication Under 2025 Guidelines
A new study estimates that 28% of U.S. adults with high blood pressure may qualify for medication under updated guidelines, highlighting a treatment g...

Report Warns Nearly 60% of U.S. Women Could Have Cardiovascular Disease by 2050
A new scientific statement projects that nearly 6 in 10 women in the U.S. will have some form of cardiovascular disease by 2050, driven by rising rate...

New AHA Statement: Up to 5 Cups of Coffee Daily Safe for Heart, but Energy Drinks Pose Risks
The American Heart Association's new scientific statement concludes that up to 400 mg of caffeine daily from coffee is safe and may lower cardiovascul...

Lexaria Reports Strong Partner Interest in GLP-1 Drug Safety at BIO 2026
Lexaria Bioscience reports positive meetings at the BIO International Convention, highlighting a shift in GLP-1 drug development focus toward safety a...

Bioactive Wound Dressings Market Projected to Reach USD 2.6 Billion by 2036, Driven by Chronic Wound Care Demand
The global bioactive wound dressings market is set to grow from USD 1.0 billion in 2026 to USD 2.6 billion by 2036, fueled by rising chronic wound pre...

Nashville Concierge Medicines Releases New Educational Content on GLP-1 Treatment for Diabetes
Nashville Concierge Medicines announces new content for confidential patient care, focusing on GLP-1 medications to help manage diabetes, blood sugar ...

U.S. Health Care Spending Surges to $5.7 Trillion in 2025, Driven by Expensive Medications
New data reveals U.S. health care spending reached $5.7 trillion in 2025, marking the third consecutive year of growth exceeding 7%, largely due to co...

